<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under
Section 12(g) of the Securities Exchange Act of 1934 or
Suspension of Duty to File Reports Under Sections 13 and
15(d) of the Securities Exchange Act of 1934
Commission File Number 0-14343
-----------------
Cabot Medical Corporation
-------------------------------------------------------------
2150 Cabot Boulevard West, Langhorne, PA 19047 (215) 752-8300
-------------------------------------------------------------
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
Common Stock
-------------------------------------------------------------
(Title of each class of securities covered by this Form)
None
-------------------------------------------------------------
(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s)
relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [ ]
Approximate number of holders of record as of the certification or
notice date: Two
---------
Pursuant to the requirements of the Securities Exchange Act of 1934
Cabot Medical Corporation has caused the certification/notice to be signed on
its behalf by the undersigned duly authorized person.
Date: September 1, 1995 By: /S/ RICHARD A. AUHLL
----------------------------------
Richard A. Auhll,
Chief Executive Officer
